LEAD THERAPEUTICS
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule IND candidates against clinically validated therapeutic targets, focused primarily on the treatment of Cancer and infectious diseases.
LEAD THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2006-01-01
Address:
San Bruno, California, United States
Country:
United States
Website Url:
http://www.leadtherapeutics.com
Total Employee:
1+
Status:
Closed
Contact:
650-737-1630
Email Addresses:
[email protected]
Total Funding:
20 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Content Delivery Network Google Universal Analytics Font Awesome Nginx Amazon IPv6
Similar Organizations
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
ImmuRx
ImmuRx, Inc. develops adjuvant platforms for the treatment of cancers and infectious diseases. The company’s product includes CD40
NAEJA-RGM Pharmaceuticals
NAEJA-RGM Pharmaceuticals engages in proprietary drug discovery work and is a player in the field of infectious disease research.
Investors List
Pappas Ventures
Pappas Ventures investment in Series A - LEAD Therapeutics
ProQuest Investments
ProQuest Investments investment in Series A - LEAD Therapeutics
Mustang Ventures
Mustang Ventures investment in Series A - LEAD Therapeutics
Official Site Inspections
http://www.leadtherapeutics.com
- Host name: a67c48129651a0940.awsglobalaccelerator.com
- IP address: 13.248.213.45
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "LEAD Therapeutics"
LEAD Therapeutics - Crunchbase Company Profile & Funding
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule IND candidates against clinically validated therapeutic …See details»
www.leadtherapeutics.com
Www.leadtherapeutics.comSee details»
Lead Therapeutics - Products, Competitors, Financials, Employees ...
LEAD Therapeutics, Inc. is a chemistry-driven drug discovery company focused on delivering novel and differentiated small molecule pre-IND candidates against clinically validated …See details»
LEAD Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, cap tables, investors, and executives for LEAD Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
LEAD Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore LEAD Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature.See details»
LEAD Therapeutics Inc - Company Profile and News
The Company researches and provides pharmaceutical therapeutics for the treatment of cancer, solid tumor, and infectious diseases. LEAD Therapeutics also provides inhibitors for the …See details»
LEAD Therapeutics acquired by BioMarin Pharmaceutical
Feb 10, 2010 · Acquiring Organization: BioMarin Pharmaceutical BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. …See details»
LEAD Therapeutics - Funding, Financials, Valuation & Investors
LEAD Therapeutics is a drug discovery company developing small molecule IND candidates for the treatment of cancer and infectious diseases.See details»
Lead Therapeutics, Inc - VentureRadar
Website: http://www.leadtherapeutics.com. Similar Companies: MyAcademy Sweden Private n/a. EASEL Biotechnologies USA Private We design systems that capture carbon dioxide, not for …See details»
BioMarin to Acquire LEAD Therapeutics - BioMarin Corporate
Feb 4, 2010 · BioMarin Pharmaceutical Inc. announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug …See details»
LEAD Therapeutics - LinkedIn
Sign in to see who you already know at LEAD Therapeutics Sign in Welcome backSee details»
LEAD Therapeutics - Pappas Capital
Pappas Ventures was one of the initial institutional investors in LEAD, a small-molecule drug discovery company that validated drug targets with rapid, exceptionally efficient lead …See details»
LEAD Therapeutics, Inc. Raises $17 Million in Series A Financing
Nov 5, 2007 · SAN BRUNO, Calif.--(BUSINESS WIRE)--LEAD Therapeutics, Inc., a chemistry-driven drug discovery company, today announced it has raised $17 million in Series A …See details»
BioMarin to acquire LEAD Therapeutics - Pappas Capital
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug …See details»
BioMarin inks $97M deal to buy LEAD Therapeutics
Feb 5, 2010 · Novato, CA-based BioMarin has struck a deal to acquire LEAD Therapeutics, a small biotech with a pre-clinical oral oncology drug in the pipeline for genetically defined cancers.See details»
Lead Therapeutics - CB Insights
Explore {Lead Therapeutics's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Emerging Drug Developer: LEAD Therapeutics | Fierce Biotech
Nov 15, 2007 · LEAD Therapeutics has a catchy acronym built into its name, a trendy business model, a seasoned executive team and $17 million. Now, the company can set out to see if …See details»
BioMarin Pharmaceutical to acquire Lead Therapeutics
Feb 7, 2010 · Biopharmaceutical company BioMarin Pharmaceutical announced Feb. 5 that it has entered into a stock purchase agreement to acquire San Bruno, Calif.-based LEAD …See details»
BioMarin to Acquire LEAD Therapeutics | Fierce Biotech
Feb 5, 2010 · BioMarin will host a conference call and webcast to discuss the acquisition of LEAD Therapeutics today, Thursday, February 4, at 5:00 p.m. ET. This event can be accessed on …See details»
BioMarin to Acquire LEAD Therapeutics - Pharmaceutical …
Feb 5, 2010 · BioMarin Pharmaceutical Inc.has entered into a stock purchase agreement to acquire LEAD Therapeutics, Inc. (LEAD), a small private drug discovery and early stage …See details»